spacer
home > pmps > Spring 2008
PUBLICATIONS

Pharmaceutical Manufacturing and Packing Sourcer

pmps
Spring 2008
At the cutting edge of the latest industry developments, Samedan is adept at keeping the information you need at your fingertips. PMPS provides a unique platform of communication for the market across Europe, North America and the rest of the developed world. To find out what's hot in the world of pharmaceuticals, take a look below at the range of articles featured in this issue of PMPS.
   
Text
PDF
bullet
Manufacturing
There are major benefits on offer to those that implement a strategy to help manage data and knowledge throughout the drug development cycle; Pietro Forgione at IDBS explores the options.  
download pdf
Dave Scott of Tepnel Research Products & Services considers why the number of drugs receiving approval has shrunk, claiming it is largely due to failures in stability testing.  
download pdf
As pharmaceutical packaging companies are on the lookout for innovative technologies, Bengt Stom of ABB Robotics examines those aiming to to reduce costs, offer greater pack varieties and add value through packaging design.  
download pdf
Steve Hemsley from Lanner explores ways that companies can ensure that they are achieving optimal levels of efficiency in order to stay ahead of the pack.  
download pdf
bullet
Drug Delivery 
Prefilled syringes are showing themselves to be increasingly appealing due to the wide range of benefits they offer to both pharmaceutical companies and patients. Manfred Zurkirch at Dividella AG investigates how recent developments will affect the future of this technology.  
download pdf
Automatic injection devices are becoming an ever-more practical drug delivery system, and as such the demand for them is always growing. Tim Barrow-Williams and Rosie Burnell at PA Consulting consider the benefits the technology affords to both businesses and end-users.  
download pdf
Drug administration methods are a crucial consideration in the success of a product. Patrice Lewko at Rexam measures how transdermal gels are becoming a more realistic option for pharmaceutical manufacturers, weighing this against the challenges that lie ahead in finding suitable dosing devices.  
download pdf
Nasal and pulmonary delivery methods have been successful in safely administering drugs to patients. However, they make it difficult for the patient to keep track of their dosage. Pierre Carlotti at Valois proposes how drug delivery devices can evolve to help counter this problem.  
download pdf
bullet
Formulations, Ingredients and Excipients
The outsourcing of inhalation device development is commonplace today – Jan Andersson at Bang & Olufsen Medicom analyses why the development of pMDIs is being handed over to specialised suppliers, and what advantages this can bring.  
download pdf
Until now, omega 3 has been better known as a generic nutritional supplement; Dr Miquel Mir of Croda Europe Ltd insists that we should change our perception of this fatty acid as it can have a very positive effect in helping to reduce inflammation.  
download pdf
As the importation of pharmaceutical products into Europe is becoming more strictly controlled, Ken Caldicott at Brecon Pharmaceuticals examines the key considerations available to those companies aiming to successfully negotiate this regulatory minefield.  
download pdf
In an era of increasingly complex drug formulations, it is important to develop technologies capable of analysing such products. Detlef Beckers at PANalytical BV proposes X-ray powder diffraction as an ideal solution.  
download pdf
bullet
IT and Logistics
Rodney Steel of the BCMPA advises how finding the right specialist to handle the manufacturing, packing and delivering of goods could prove a worthwhile investment.  
download pdf
Andy Silver of BSS Industrial outlines why it is important to check that the company supplying the component parts of your production line understands each challenge.  
download pdf
bullet
PACKING, PACKAGING & ANTI-COUNTERFEITING
Thomas Völcker of Schreiner ProSecure discusses the reasons why the pharmaceutical arena is so appealing to counterfeiters – an increasingly concerning problem for every aspect of the industry. He analyses how badly the industry is affected by this problem; and the latest security measures attempting to tackle the issue.  
download pdf
The problem of patients being supplied with counterfeit drugs increases; David Lyon at GS1 UK analyses new security measures being adopted by pharmaceutical companies.  
download pdf
Dr Thomas Dries at Honeywell Specialty Films, along with Charles Rowlands and Amy Morgan at RM Consulting, investigates how thermoformed primary packaging can offer companies a new lease of life.  
download pdf
Storing and packaging a drug in a safe manner is a vital consideration in its development cycle. Adrian Possumato of Multisorb Technologies discusses pseudo-empirical modelling as regards this issue.  
download pdf
Bill Martineau of the Freedonia Group explains how to improve the safety, effectiveness and ease of IV administration and injectable drug delivery.  
download pdf
bullet
COOL CHAIN
Recent developments in French guidelines on pharmaceutical logistics are having a significant effect on packaging specification and procedures both from and within France. Tim Jennings of Emball’iso takes a closer look at the changes afoot.  
download pdf
Robert Simpson of Jet Environmental investigates the methods available to help remedy the problem of managing extreme changes in temperature.  
download pdf
bullet
PATIENT COMPLIANCE
As pressure increases on the pharmaceutical industry to offer more value for money, David Spackman of MeadWestVaco explores the potential impact of investment in packaging in order to improve patient compliance to drug treatments and therefore reduce wastage.  
download pdf
A key concern for the pharmaceutical industry is the adherence of patients to their medication regimens – failure to do so results in substantial numbers of prescribed drugs being discarded each year. Tassilo Korab at HCPC examines the methods available to manufacturers to help improve patient adherence rates, and therefore successful treatment.  
download pdf
   
spacer
Edited by
Randice Altschul
Chief Executive Officer at Pop Test and Palisades Therapeutics

Published quarterly in
February, May,
August and November

News and Press Releases

POP TEST ADDRESSES THE PROBLEM OF UNRELIABLE DATA FROM CONTINUOUS GLUCOSE MONITORS

A major insight relating to the unreliability of data from continuous glucose monitors was published in the Nature journal, “Scientific Reports”, by Neil Theise, MD., the Lead Scientist of Pop Test, LLC and colleagues. The discovery of the “Interstitium”, a newfound human organ, by Dr. Theise and his collaborators, can be viewed by using the link https://www.nature.com/articles/s41598-018-23062-6 Continual glucose monitoring via an indwelling cutaneous needle measuring glucose in interstitial fluid (now identified to be in the “interstitium”) has been a game changer in the treatment of type 1 diabetes mellitus because of its accuracy. However, the needles used to collect this glucose containing fluid often fail in as little as a week. Despite the reliance on fluid from this space, the microanatomy of the interstitium has never been defined. The sensors currently in use were developed with the presumption of interstitial fluid being located somewhere in the sub-epidermal layers of the skin, but the actual anatomy relating to needle placement was always unclear.
More info >>

White Papers

Device Develop for Combo Products

Phillips-Medisize

Combination products are defined as therapeutics combining two or more products (drug/device, biologics/device, biologics/drugs or drug/device/biologics), regulated and sold as a single unit. As these pharmaceutical and biological therapies and treatments have evolved, so has the need to develop appropriate delivery mechanisms for these applications. When developing a combination product, there are many things that need to be considered – the critical relationships between device development and the pharmaceutical or biologic, early establishment of regulatory and clinical strategies, understanding ‘user’ needs, determining product requirements, as well as, device manufacturing variation.
More info >>

Industry Events

On Helix 2018

10-11 July 2018, The Cambridge Building, Babraham Research Campus

ON Helix is a two-day event aimed at informing delegates of how to turn early stage inventions and ideas into innovative health treatments (new medicines, novel biomarkers, useful medical devices or improved medical practices).
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement